Mar 112020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, GA – Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with the serious back of the eye diseases, announced today that George Lasezkay, Pharm.D., J.D., has been appointed President and CEO effective March 1, 2020, and will continue to serve ...

Clearside Biomedical appoints Board member Dr George Lasezkay as CEO

From:: Clearside Biomedical appoints Board member Dr George Lasezkay as CEO

Sorry, the comment form is closed at this time.